MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
504.90%
Quick Ratio
504.90%
Cash Ratio
496.15%
Debt to Asset Ratio
19.85%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Property and equipment, net
    • Right-of-use assets
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
155,098
186,629
15,483
35,132
Other current assets and prepaid expenses
2,735
2,130
7,386
4,141
Total current assets
157,833
188,759
22,869
39,273
Property and equipment, net
771
566
608
640
Right-of-use assets
565
417
575
791
Total assets
159,169
189,742
24,052
40,704
Accounts payable
12,665
11,011
10,138
7,918
Accrued expenses
17,852
22,432
18,645
19,454
Other current liabilities
743
4,920
1,835
2,707
Total current liabilities
31,260
38,363
30,618
30,079
Operating lease liabilities
328
146
107
126
Total long-term liabilities
328
146
107
126
Total liabilities
31,588
38,509
30,725
30,205
Common stock, 0.0001 par value 500,000,000 shares authorized as of june 30, 2026 and december 31, 2025, and 13,644,467 and 12,038,263 shares issued and outstanding as of june 30, 2026 and december31, 2025, respectively
13
11
9
9
Additional paid-in capital
800,054
789,324
599,241
597,179
Accumulated other comprehensive income
2,772
3,057
2,648
2,582
Accumulated deficit
-675,258
-641,159
-608,571
-589,271
Total stockholders equity (deficit)
127,581
151,233
-6,673
10,499
Total liabilities and stockholders equity (deficit)
159,169
189,742
24,052
40,704
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$155,098K (180.42%↑ Y/Y)Other current assetsand prepaid...$2,735K (-39.65%↓ Y/Y)Total current assets$157,833K (163.75%↑ Y/Y)Property and equipment,net$771K (25.98%↑ Y/Y)Right-of-use assets$565K (-42.05%↓ Y/Y)Total assets$159,169K (159.11%↑ Y/Y)Total liabilities andstockholders equity...$159,169K (159.11%↑ Y/Y)Total stockholdersequity (deficit)$127,581K (276.22%↑ Y/Y)Total liabilities$31,588K (14.79%↑ Y/Y)Accumulated deficit-$675,258K (-19.79%↓ Y/Y)Additional paid-in capital$800,054K (34.45%↑ Y/Y)Total currentliabilities$31,260K (14.45%↑ Y/Y)Total long-termliabilities$328K (60.00%↑ Y/Y)Accumulated othercomprehensive income$2,772K (9.78%↑ Y/Y)Common stock, 0.0001par value...$13K (44.44%↑ Y/Y)Accrued expenses$17,852K (-1.44%↓ Y/Y)Accounts payable$12,665K (60.46%↑ Y/Y)Other currentliabilities$743K (-43.15%↓ Y/Y)Operating leaseliabilities$328K (60.00%↑ Y/Y)

IMMUNIC, INC. (IMUX)

IMMUNIC, INC. (IMUX)